Endoluten vs Foxo4-DRI

Pineal-targeted peptide complex that modulates melatonin synthesis pathways and circadian gene expression. May help restore age-related decline in pineal activity and improve circadian rhythm regulation.

A short peptide bioregulator derived from pineal gland tissue, developed by the Khavinson Institute. Studied for circadian rhythm restoration, melatonin pathway support, and longevity — addressing the age-related decline in pineal gland function.

D-retro-inverso peptide that disrupts Foxo4/p53 interaction in senescent cells; restores p53-mediated apoptosis selectively in senescent cells; clears cellular "zombie cells"

A breakthrough senolytic peptide that selectively eliminates senescent cells by restoring their ability to undergo apoptosis. Produced dramatic rejuvenation effects in preclinical studies.